Unlock Clear, Phase Appropriate Risk Assessment, Regulatory Alignment & Vendor Management Strategies to Build a Stronger Raw Material Framework for Cell, Gene & Stem Cell Therapies
Cell and gene therapies are advancing into late-stage development and commercialization, where raw materials have become a critical determinant of whether programmes succeed or fail. Small inconsistencies that once went unnoticed are now triggering regulatory scrutiny, inflating cost of goods, and causing delays that put timelines and patient access at risk.
Following the sunshine to San Diego, the 3rd Raw Materials for Cell & Gene Therapy Summit is the only dedicated forum designed to help you take control of this risk. Through technical case studies and cross-functional discussion, you will uncover practical, phase-appropriate strategies to manage variability, strengthen supplier qualification, and build raw material frameworks that scale confidently from early development through to commercial manufacturing.
By joining leading experts across quality, MSAT, supply chain, and process development, you will engage in face-to-face discussions on how peers are defining material specifications, managing lot-to-lot variability, and making critical qualification decisions under real development pressure.
This collaborative environment enables open, candid exchange that simply cannot be replicated through reports or virtual formats. Leave with the clarity to make better decisions on raw material selection and supplier qualification, the confidence to defend them, and the relationships needed to accelerate your path to reliable, cost-effective, and scalable cell and gene therapy manufacturing.
The workshop sessions were really valuable, the discussion was so pertinent to the issues I deal with on a daily basis.
Associate Director Supply Chain Planning & Strategy, Rocket Pharmaceuticals, 2024 Attendee
This summit brings together raw material experts in the CGT space to discuss common challenges and align on potential solutions. It is a great opportunity to exchange information and address problems with industrial peers.
Director, Head of Material Development, Kite Pharma, 2026 Speaker
I appreciated having a variety of industry experts, ranging from smaller biotech companies to large pharma companies and independent experts. This helped encourage fruitful discussions.
Buyer, Abeona Therapeutics, 2025 Attendee
Explore the Full Event Guide
- 16+ cross-functional experts spanning quality, MSAT, and supply chain shaping raw material strategies
- 2 in-depth workshops to deep dive into particulate risk and material transitions before they delay your programme
- Dedicated networking sessions & interactive roundtables designed to spark meaningful, problem-solving conversations
- Face-to-face access to peers and decision-makers to exchange practical experiences not captured in published reports
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Dive into technical case studies and working sessions designed to help you manage raw material risk, variability, and scale-up challenges with confidence.
Partner With Us
Position your solutions in front of cell and gene therapy leaders actively seeking support to strengthen material quality, reduce supply chain risks, and ensure overall manufacturing reliability.
Join Industry Leaders
Connect face-to-face with cross-functional experts to exchange candid insights and build relationships that accelerate your raw material strategy in practice.